Samsara BioCapital, L.P.

Holdings History for Kalaris Therapeutics, Inc. - Common Stock, $0.0001 par value per share (KLRS)

Symbol: KLRS on Nasdaq
Investment type: Equity / Common Stock, $0.0001 par value per share
Latest Disclosed Shares Owned: 12,953,581 shares
Security Ownership %: 56%

Srinivas Akkaraju ownership in Kalaris Therapeutics, Inc. Common Stock, $0.0001 par value per share (KLRS)

22 Dec 2025 - Srinivas Akkaraju has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 12,953,581 shares of Kalaris Therapeutics, Inc. Common Stock, $0.0001 par value per share (KLRS). This represents 56% ownership of the company. In their previous filing dated 25 Mar 2025, Samsara BioCapital, L.P. had reported owning 11,448,081 shares, indicating an increase of +13%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
Srinivas Akkaraju	56%	-7.7%	$65,674,656	12,953,581	+1,505,500	+13%	$5.07	13D/A	22 Dec 2025	22 Dec 2025, 16:17
Samsara BioCapital, L.P.	61%		$91,928,090	11,448,081			$8.03	13D	18 Mar 2025	25 Mar 2025, 19:40